These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7035415)

  • 21. A monoclonal antibody to the HLA-A3 alloantigen.
    Bourel D; Fauchet R; Genetet B; Merdrignac G; Hurez D
    Immunol Lett; 1982 Nov; 5(5):233-7. PubMed ID: 6984424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supertypic HLA-Bw4 antigen detected by a new monoclonal antibody.
    Rychlíková M; Hinzová E; Nosek J; Forejt J
    Exp Clin Immunogenet; 1986; 3(2):88-97. PubMed ID: 3274050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.
    Gaston JS; Wallace LE; Rickinson AB; Epstein MA; Pious D
    Immunogenetics; 1984; 19(6):475-86. PubMed ID: 6329950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cytotoxic monoclonal antibody specific for the private alloantigenic determinant of the HLA-B 13 molecule.
    Müller C; Herbst H; Löffler G; Ziegler A; Wernet P
    Hum Immunol; 1983 Aug; 7(4):229-37. PubMed ID: 6193088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double determinant immunoassay for HLA class I typing using serum as an antigen source.
    Russo C; Fotino M; Carbonara A; Ferrone S
    Hum Immunol; 1987 May; 19(1):69-77. PubMed ID: 3495524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of three new monoclonal antibodies detecting the allospecificities HLA-A2,w69, HLA-A3 and HLA-B13.
    Eiermann TH; Raghavachar A; Wölpl A; Ballas M; Fischer M; Goldmann SF
    Tissue Antigens; 1987 Apr; 29(4):201-7. PubMed ID: 3497470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antigen structural gene mutants selected with an allospecific monoclonal antibody.
    Pious D; Krangel MS; Dixon LL; Parham P; Strominger JL
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7832-6. PubMed ID: 6961455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.
    Lemonnier FA; Le Bouteiller PP; Olive D; Malissen B; Mishal Z; Layet C; Dubreuil J; Caillol DH; Kourilsky FM; Jordan BR
    J Immunol; 1984 Mar; 132(3):1176-82. PubMed ID: 6198381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma ray-induced mutants as a tool for the production and characterisation of monoclonal antibodies against HLA-alloantigens.
    Spring B; Pawelec G; Ziegler A
    Tissue Antigens; 1986 Apr; 27(4):201-8. PubMed ID: 3014680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of monoclonal antibodies against HLA-A2 is due to antibody bivalency.
    Holmes NJ; Parham P
    J Biol Chem; 1983 Feb; 258(3):1580-6. PubMed ID: 6185487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the specificity of DR monoclonal antibodies.
    Molinaro GA; Quaranta V; Ferrone S
    Transplant Proc; 1979 Dec; 11(4):1748-50. PubMed ID: 93799
    [No Abstract]   [Full Text] [Related]  

  • 36. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens.
    Perosa F; Tsujisaki M; Ferrone S
    J Immunol; 1987 Apr; 138(7):2202-7. PubMed ID: 2435792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones.
    Russo C; Flomenberg N; Dupont B; Ferrone S
    Cell Immunol; 1984 Oct; 88(1):228-32. PubMed ID: 6206957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
    McMichael AJ; Parham P; Brodsky FM; Pilch JR
    J Exp Med; 1980 Aug; 152(2 Pt 2):195s-203s. PubMed ID: 6967937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A xenogeneic monoclonal antibody recognizing specificities controlled by HLA-A and B alleles.
    Richiardi P; Amoroso A; Crepaldi T; Ceppellini R; Trucco M
    Immunogenetics; 1981 Mar; 12(5-6):615-26. PubMed ID: 6783514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.